Gene-Specific Therapy for Congenital Long QT Syndrome: Are We There Yet?

Abstract

D uring the past 2 decades, there has been substantial progress in the study of molecular and cellular arrhythmogenesis in inherited cardiac channelopathies. The majority of these life-threatening primary arrhythmia syndromes have been associated with mutations in specific genes, leading not only to a better diagnosis but also, to some degree, to improved… (More)
DOI: 10.1016/j.jacc.2015.12.030

Topics

Cite this paper

@article{Arbelo2016GeneSpecificTF, title={Gene-Specific Therapy for Congenital Long QT Syndrome: Are We There Yet?}, author={Elena Arbelo and Georgia Sarquella-Brugada and Josep Brugada}, journal={Journal of the American College of Cardiology}, year={2016}, volume={67 9}, pages={1059-61} }